Book Days ¡Hasta 50% OFF y envío rápido!  Ver más

Enviar a
CERCADO DE LIMA, Lima
0

Mi Cuenta

  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

menú

Selecciona tu país

América

Europa

Resto del mundo

portada A National Strategy for the Elimination of Hepatitis B and C. Phase Two Report
Formato
Libro Físico
Editorial
Autor
Año
2017
N° páginas
296
Encuadernación
Tapa Blanda
Dimensiones
22.90 x 15.20 x 2.50 cm
ISBN13
9780309457293

A National Strategy for the Elimination of Hepatitis B and C. Phase Two Report

Board On Population Health And Public Health Practice;Gillian J. Buckley;Brian L. Strom;Health And Medicine Division;Engineering, And Medicine National Academies Of Sciences;Committee On A National Strategy For The Elimination Of Hepatitis B And C (Autor) · National Academies Press · Tapa Blanda

A National Strategy for the Elimination of Hepatitis B and C. Phase Two Report - Board on Population Health and Public Health Practice;Gillian J. Buckley;Brian L. Strom;Health and Medicine Division;Engineering, and Medicine National Academies of Sciences;Committee on a National Strategy for the Elimination of Hepatitis B and C

Más barato Libro Nuevo Importado
Envío: 13 a 17 días háb.
S/ 544,98S/ 245,24
-55%
Más rápido Libro Nuevo Importado
Envío: 9 a 16 días háb.
S/ 621,00S/ 310,50
-50%
Costos de importación incluídos en el precio ✅
Libro Nuevo Más barato

Quedan 50 unidades

S/ 245,24
Llega entre el 10 Ago y el 17 Ago a CERCADO DE LIMA, Lima. Seleccionar ubicación

Elige la lista en la que quieres agregar tu producto o crea una nueva lista

Ir a Mis Listas
Calcula el costo de envío

Reseña del libro "A National Strategy for the Elimination of Hepatitis B and C. Phase Two Report"

Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the second of two, builds off the conclusions of the first report and outlines a strategy for hepatitis reduction over time and specific actions to achieve them. Table of ContentsFront MatterSummary1 Introduction2 Targets for Elimination3 Public Health Information4 Essential Interventions5 Service Delivery6 Financing Elimination7 ResearchAppendix A: Population Health Impact and Cost-Effectiveness of Chronic Hepatitis B Diagnosis, Care, and Treatment in the United StatesAppendix B: Modeling the Elimination of Hepatitis C in the United StatesAppendix C: Public Meeting AgendaAppendix D: Committee Biographies

Opiniones del libro

Ver más opiniones de clientes
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Preguntas frecuentes sobre el libro

¿El libro es original?

Todos los libros de nuestro catálogo son Originales.

¿Cuál es la encuadernación de este libro?

La encuadernación de esta edición es Tapa Blanda.

Preguntas y respuestas sobre el libro

¿Tienes una pregunta sobre el libro? Inicia sesión para poder agregar tu propia pregunta.

Opiniones sobre Buscalibre

Ver más opiniones de clientes